logo
ProjectForthcoming

TRansferring Analytical Cancer-detection Expertise across Systems

The status, timeline and source of this project. A free account opens every field.

Source: EU Funding & Tenders Portal

Several research groups have developed distinct analytical methods for detecting cancer earlier using routine primary care data, including platelet-based risk markers (Exeter), blood test trajectory modelling (Oxford/BLOTTED), diagnostic interval measurement (Aarhus/CaP), and machine learning risk stratification (Karolinska/STEADY-CAN). These methods have been developed largely in parallel, on dif

Status
Prospective
Sector
Education
Location
Ireland, Sweden, Denmark, United Kingdom
Updated
19 Nov 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about TRansferring Analytical Cancer-detection Expertise across Systems

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “TRansferring Analytical Cancer-detection Expertise across Systems” is an infrastructure initiative in the Education sector, located in Ireland, Sweden, Denmark, United Kingdom. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

forthcoming

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

Several research groups have developed distinct analytical methods for detecting cancer earlier using routine primary care data, including platelet-based risk markers (Exeter), blood test trajectory modelling (Oxford/BLOTTED), diagnostic interval measurement (Aarhus/CaP), and machine learning risk stratification (Karolinska/STEADY-CAN). These methods have been developed largely in parallel, on different national datasets, within different health systems. No systematic attempt has been made to test whether signals identified by one method replicate when applied in a different system. TRACES (TRansferring Analytical Cancer-detection Expertise across Systems) addresses this gap through structured researcher mobility. By moving people, not patient data, across a consortium spanning seven countries and two sectors, TRACES will produce the first systematic cross-validation of early cancer detection methods across health systems. Secondments will transfer established methods to new datasets, identify which pre-diagnostic signals are robust across systems and which are local artefacts, and determine the minimum data maturity required before each method becomes deployable. The key output is a Data Readiness Framework specifying which methods work in which data environments, directly informing national implementation decisions. The consortium comprises 6 beneficiaries and 3 associated partners across Ireland, the UK, Sweden, Denmark, South Africa, Australia, and Singapore. RCSI (Ireland) coordinates. The non-academic partner (Centric Health) leads translation of outputs into clinical practice through GP-facing usability evaluation of risk stratification tools. The project runs for 48 months with 260 person-months of staff exchanges. Beyond the funded period, TRACES will continue as a sustained research cooperative embedded within the Ca-PRI (Cancer in Primary Care) international network, ensuring long-term methodological alignment and cross-system learning.

Location

Country

Ireland, Sweden, Denmark, United Kingdom

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Education

Article published date

2026-10-15

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project